Gopi Shanker

Gopi Shanker

Company: Novartis Institutes for Biomedical Research

Job title: Director, Head of Psychiatry

Bio:

Gopi Shanker has spent over 19 years working in the area of neuroscience drug discovery and has led preclinical and clinical drug discovery programs in the areas of neuropsychiatry, neurodegeneration and pain/migraine. Gopi completed his doctoral work in neuroendocrinology at the Indian Institute of Science, Bangalore (India) and his post-doctoral work in sensory neurobiology at the Mt. Sinai School of Medicine, New York. He started his research in drug discovery at Regeneron Pharmaceuticals and developed a deeper focus on discovering neuroscience therapies at Amgen thereafter. He joined the Neuroscience disease area at Novartis in 2013. At Novartis, Gopi is responsible for setting the strategy and leading the neuropsychiatry unit as well as initiating and establishing drug discovery programs focused on neuropsychiatric and neurodevelopmental disorders and advancing them into the clinic.

Seminars:

Chair’s Closing Remarks 4:00 pm

Read more

day: Day Two

Chair’s Opening Remarks 9:00 am

Read more

day: Day Two

Chair’s Closing Remarks 5:30 pm

Read more

day: Day One

Kick-off Panel Discussion: What is Preventing Experts from Redefining the Field & Developing Transformative Drugs for Psychiatric Patients in Need? 8:40 am

Read more

day: Day One

Chair’s Opening Remarks 8:30 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.